Detumomab
Detumomab is a mouse monoclonal antibody[1] developed for the treatment of cancer.
References
|
---|
| Tumor ("-t(u[m])-") | Human ("-tumu-") | |
---|
| Mouse ("-tumo-") | |
---|
| Chimeric ("-tuxi-") | |
---|
| Humanized ("-tuzu-") | |
---|
| Rat/mouse hybrid ("-tumaxo-") | |
---|
| Chimeric + humanized ("-tuxizu-") | |
---|
|
---|
| |
---|
| Description |
- Tumor suppressing and oncogenes
- Tumor markers
- Carcinogen
|
---|
| Disease |
- Neoplasms and cancer
- Symptoms and signs
- Paraneoplastic
|
---|
| Treatment |
- Radiotherapy
- Drugs
- Immunotherapy
- intracellular chemotherapeutics
- extracellular chemotherapeutics
- adjuvant detoxification
|
---|
|
|